Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Identification of the First Marine-Derived Opioid Receptor "Balanced" Agonist with a Signaling Profile That Resembles the Endorphins.

Johnson TA, Milan-Lobo L, Che T, Ferwerda M, Lambu E, McIntosh NL, Li F, He L, Lorig-Roach N, Crews P, Whistler JL.

ACS Chem Neurosci. 2017 Mar 15;8(3):473-485. doi: 10.1021/acschemneuro.6b00167. Epub 2016 Nov 22.

2.

Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice.

Alongkronrusmee D, Chiang T, van Rijn RM.

Drug Alcohol Depend. 2016 Oct 1;167:190-8. doi: 10.1016/j.drugalcdep.2016.08.017. Epub 2016 Aug 21.

PMID:
27567436
3.

The delta opioid receptor tool box.

Vicente-Sanchez A, Segura L, Pradhan AA.

Neuroscience. 2016 Dec 3;338:145-159. doi: 10.1016/j.neuroscience.2016.06.028. Epub 2016 Jun 24. Review.

PMID:
27349452
4.

Delta Opioid Pharmacology in Relation to Alcohol Behaviors.

Alongkronrusmee D, Chiang T, van Rijn RM.

Handb Exp Pharmacol. 2016 Jun 18. [Epub ahead of print]

PMID:
27316912
5.

Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.

Huang P, Tunis J, Parry C, Tallarida R, Liu-Chen LY.

Eur J Pharmacol. 2016 Jun 15;781:53-9. doi: 10.1016/j.ejphar.2016.03.061. Epub 2016 Apr 1.

6.

β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake.

Chiang T, Sansuk K, van Rijn RM.

Br J Pharmacol. 2016 Jan;173(2):332-43. doi: 10.1111/bph.13374.

7.

Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research.

Fritz BM, Boehm SL 2nd.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:297-308. doi: 10.1016/j.pnpbp.2015.05.012. Epub 2015 Jun 2. Review.

8.

Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?

Blum K, Febo M, Thanos PK, Baron D, Fratantonio J, Gold M.

Mol Neurobiol. 2015 Dec;52(3):1862-1869. doi: 10.1007/s12035-015-9110-9. Epub 2015 Mar 10. Review.

9.

Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.

Bailey CP, Husbands SM.

Expert Opin Drug Discov. 2014 Nov;9(11):1333-44. doi: 10.1517/17460441.2014.964203. Epub 2014 Sep 25. Review.

10.

In vivo opioid receptor heteromerization: where do we stand?

Massotte D.

Br J Pharmacol. 2015 Jan;172(2):420-34. doi: 10.1111/bph.12702. Epub 2014 Jul 1. Review.

11.

The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Klenowski P, Morgan M, Bartlett SE.

Br J Pharmacol. 2015 Jan;172(2):297-310. doi: 10.1111/bph.12618. Epub 2014 Jul 1. Review.

12.

15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse.

Charbogne P, Kieffer BL, Befort K.

Neuropharmacology. 2014 Jan;76 Pt B:204-17. doi: 10.1016/j.neuropharm.2013.08.028. Epub 2013 Sep 10. Review.

13.

Delta opioid receptors in brain function and diseases.

Chu Sin Chung P, Kieffer BL.

Pharmacol Ther. 2013 Oct;140(1):112-20. doi: 10.1016/j.pharmthera.2013.06.003. Epub 2013 Jun 10. Review.

14.

Pharmacological traits of delta opioid receptors: pitfalls or opportunities?

van Rijn RM, Defriel JN, Whistler JL.

Psychopharmacology (Berl). 2013 Jul;228(1):1-18. doi: 10.1007/s00213-013-3129-2. Epub 2013 May 7. Review.

15.

A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations.

Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; ADNI.

Hum Brain Mapp. 2014 Apr;35(4):1226-36. doi: 10.1002/hbm.22247. Epub 2013 Feb 21.

16.

Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.

Ashenhurst JR, Bujarski S, Ray LA.

Pharmacol Biochem Behav. 2012 Dec;103(2):253-9. doi: 10.1016/j.pbb.2012.08.019. Epub 2012 Aug 27.

17.

Chronic ethanol potentiates the effect of neuropeptide s in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects.

Enquist J, Ferwerda M, Madhavan A, Hok D, Whistler JL.

Neuropsychopharmacology. 2012 Oct;37(11):2436-45. doi: 10.1038/npp.2012.102. Epub 2012 Jun 27.

18.

Alcohol self-administration, anxiety, and cortisol levels predict changes in delta opioid receptor function in the ventral tegmental area.

Mitchell JM, Margolis EB, Coker AR, Fields HL.

Behav Neurosci. 2012 Aug;126(4):515-22. doi: 10.1037/a0029027. Epub 2012 Jun 18.

19.

Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists.

van Rijn RM, Brissett DI, Whistler JL.

Drug Alcohol Depend. 2012 Apr 1;122(1-2):156-9. doi: 10.1016/j.drugalcdep.2011.09.024. Epub 2011 Oct 21.

20.

The delta opioid receptor: an evolving target for the treatment of brain disorders.

Pradhan AA, Befort K, Nozaki C, Gavériaux-Ruff C, Kieffer BL.

Trends Pharmacol Sci. 2011 Oct;32(10):581-90. doi: 10.1016/j.tips.2011.06.008. Epub 2011 Sep 17. Review.

Supplemental Content

Support Center